Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes RNA interference (RNAi) therapeutics. Its medicines use gene silencing to address diseases including hereditary transthyretin-mediated amyloidosis, acute hepatic porphyria, primary hyperoxaluria type 1, and hypercholesterolemia. The company also advances a clinical pipeline of investigational RNAi medicines across cardiovascular, metabolic, neurological, rare-disease, and other therapeutic areas. Founded in 2003, Alnylam is headquartered in Cambridge, Massachusetts.
Address
675 West Kendall Street, Henri A. Termeer Square
Cambridge, 02142
United States
Year founded
2003
Number of employees
2,000-3,000
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Alnylam Pharmaceuticals logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/alnylam.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
